GlassScriptPhysician profile
Leila Neshatian
NPI 1710275722
$29,472.04
in general payments reported to CMS, 2019-2025
12 companies · $2,904 in 2025
The $2,904 reported for 2025 was more than what 86% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2021: $1,207 · 2022: $25K · 2023: $282 · 2024: $304 · 2025: $2,904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,400 · Food and Beverage: $1,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,400.00 |
| Food and Beverage | $1,090.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $18,550.00 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $7,236.77 | 2021-2025 | Xifaxan, Trulance |
| Ardelyx, INC. | $1,854.90 | 2022-2025 | Ibsrela |
| Gi Supply, INC. | $1,125.00 | 2021 | |
| Vibrant Gastro, INC. | $142.32 | 2024 | Vibrant Starter Kit |
| Cook Biotech Incorporated | $126.32 | 2023 | |
| Alnylam Pharmaceuticals INC. | $113.31 | 2019 | |
| Medtronic, INC. | $103.90 | 2021-2025 | Interstim |
| Medtronic USA, INC. | $81.87 | 2019 | |
| Allergan, INC. | $71.76 | 2019 | |
| Teleflex LLC | $36.44 | 2025 | Solesta |
| Mauna Kea Technologies, INC. | $29.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leila Neshatian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.